Hirotoshi Kakuta Selected Research

Hirotoshi Kakuta Research Topics

3	Insulin Resistance 04/2014 - 01/2005
2	Hyperphosphatemia 11/2015 - 06/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2011 - 05/2003
2	Hepatocellular Carcinoma (Hepatoma) 08/2003 - 05/2003
2	Hypercholesterolemia 05/2003 - 03/2002
1	Acidosis 11/2015
1	Chronic Renal Insufficiency 11/2015
1	Essential Hypertension 01/2011
1	Hypertension (High Blood Pressure) 01/2011
1	Body Weight (Weight, Body) 12/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2006
1	Atherosclerosis 01/2005
1	Hypertriglyceridemia 05/2003

3	Glucose (Dextrose)FDA LinkGeneric 04/2014 - 01/2005
2	bixalomerIBA 11/2015 - 06/2013
2	Angiotensin II Type 1 Receptor BlockersIBA 04/2014 - 12/2006
2	Telmisartan (Micardis)FDA Link 01/2011 - 12/2006
2	Insulin (Novolin)FDA Link 12/2006 - 01/2005
2	Atorvastatin (Lipitor)FDA Link 01/2005 - 05/2003
2	Farnesyl-Diphosphate Farnesyltransferase (Squalene Synthase)IBA 08/2003 - 05/2003
2	YM 53601IBA 05/2003 - 03/2002
1	Sulfates (Sulfates, Inorganic)IBA 11/2015
1	Adenine FDA LinkGeneric 11/2015
1	Sevelamer (RenaGel)FDA Link 11/2015
1	Phosphorus (Red Phosphorus)IBA 11/2015
1	Phosphates (Orthophosphate)IBA 11/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2006
1	Angiotensin IIIBA 12/2006
1	Triglycerides (Triacylglycerol)IBA 12/2006
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2006
1	Messenger RNA (mRNA)IBA 01/2005
1	ElementsIBA 01/2005
1	SterolsIBA 01/2005
1	HDL CholesterolIBA 01/2005
1	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 01/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2005
1	carbazoleIBA 08/2003
1	QuinuclidinesIBA 05/2003
1	CholesterolIBA 05/2003
1	Lipoproteins (Lipoprotein)IBA 05/2003
1	Sucrose (Saccharose)IBA 05/2003
1	LipidsIBA 05/2003